Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SAFE: Surveillance And Follow-up Evaluation of FemBloc

NCT07924293 is registered in ClinicalTrials.gov with Femasys Inc. as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07924293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
SAFE: Surveillance And Follow-up Evaluation of FemBloc
Lead sponsor
Femasys Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
October 22, 2025
Completion date
July 31, 2027
Enrollment
200 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

contraception

Arms

As registered; 1 arm.

  • FemBloc FemBloc Permanent Birth Control

    Device

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Degree of patient satisfaction At time of procedure

    To evaluate the acceptance of the FemBloc procedure in real life by female candidates by measuring the degree of satisfaction reported by participants on Likert scale (1-5, 5=highest satisfaction)

Lead sponsor's other trials

Femasys Inc., most recent start first.